Efficacy and Safety Study of a Modified XELOX Regimen in First-Line Treatment of Metastatic Colorectal Adenocarcinoma

ABSTRACT: This is an open-label, phase II study to evaluate the efficacy and safety of a modified regimen of oxaliplatin and capecitabine on metastatic colorectal adenocarcinoma in the first-line therapy.

DISEASE(S): Adenocarcinoma,Colorectal Adenocarcinoma,Colorectal Cancer

PROVIDER: 2121875 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR